Company intelligence / Profile preview
Amnol
- Ownership
- Private
- Employees
- ~35
- Development stage
- Other
Overview
Amnol is an Italian pharmaceutical company specializing in the development and commercialization of nutraceuticals, medical devices, and dermocosmetics. Founded in 1978 and based in Novara, the company focuses on therapeutic areas such as angiology, proctology, orthopedics, and dermatology. Amnol's product portfolio, which includes well-known brands like Venoplant and Artrosulfur, is designed to provide evidence-based solutions for vascular health, joint care, and skin disorders. The company maintains a strong presence in the Italian market through a dedicated network of medical representatives and a commitment to scientific research. Amnol continues to expand its offerings by integrating high-quality ingredients with innovative delivery systems to improve patient well-being.
- Therapeutic areas
- CardiovascularDermatologyRheumatologyGastroenterologyOphthalmology
- Modalities
- Small moleculeMedical device
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Amnol.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amnol.